David Shaw’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
David Shaw's ALDR Position: Q4 2019 in Review
David Shaw sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 68,923 shares — an estimated $1.3M sold.
David Shaw first reported a position in ALDR in Q4 2014 and held it in 12 quarters. The position peaked at $2.06M in Q1 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- David Shaw reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- David Shaw sold 68,923 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.3M.
- David Shaw first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 12 quarters.
- David Shaw's Alder Biopharmaceuticals position peaked at $2.06M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.